Introduction: Excessive portal venous pressure in the liver remnant is an independent factor in the occurrence of posthepatectomy liver failure and small-for-size syndrome. The baseline portal pressure prior to hepatectomy was not considered previously. The aim of this study is to assess the impact of portal pressure change during hepatectomy on the patient outcome. Material and Methods: Prospective observational study including 30 patients subjected to intraoperative measurement of portal pressure before and after hepatectomy. This variation was related to the patient outcome. Control group evaluation was assessed. Patient, disease and procedure features were considered. The optimal cut-off of portal pressure variation was determined. Linear regression or logistic regression was applied to identify predictors of the outcome.
INTRODUCTION
Major hepatectomy (MH) is currently the standard treatment for benign and malignant liver disease, allowing also collecting grafts in living donor liver transplantation (LDLT). 1, 2 Over the last years, there has been an increase in survival and more acceptable morbidity and mortality rates in patients undergoing MH or LDLT. 3, 4 However, despite this progress, the mortality rate after MH remains worrying, with liver failure being its main cause. 1, 5, 6 Several studies suggest that hepatic failure after MH is due to reduced liver volume and hemodynamic changes, which increase oxidative stress, leading to necrosis and apoptosis. [7] [8] [9] [10] [11] [12] Although portal venous pressure (PVP) and flow play an important role in hepatic regeneration after hepatectomy, these rapid hemodynamic changes may lead to excessive portal venous pressure to the liver remnant, consequent sinusoidal injury, destruction of the hepatic parenchyma and hepatic dysfunction. [7] [8] [9] [10] [11] A similar process has been described in LDLT, which allowed identifying small-for-size syndrome (SFSS) as an important clinical entity. More recently, the concept of 'small-for-flow' based on the assumption that post-hepatectomy liver failure (PHLF) and SFSS after LDLT would have the same origin, has been proposed: the excessive portal venous flow to the liver remnant. 7 Several studies have shown the importance of PVP early assessment as an independent predictor for PHLF occurrence. 1, 7, 8, 11, [13] [14] [15] [16] However, few published studies attribute a cut-off of PVP, above which PHLF or SFSS become very likely. In addition, they do not consider other factors which influence intraoperative PVP, namely, the baseline PVP prior to hepatectomy.
The aim of this study is to assess the impact of PVP variation during hepatectomy on cytolysis, hepatic function, morbidity and mortality.
MATERIAL AND METHODS Inclusion criteria and ethical authorization
Patients proposed for liver resection, without liver cirrhosis or anaesthetic contraindication, with a future liver remnant (FLR) > 30% and benign or malignant diagnosis were included in this study. All patients authorized the participation through informed consent, approved by the Ethics Committee of the Vila Nova de Gaia/Espinho Hospital, which also approved the study protocol.
Sample characterization
The sample included 30 patients undergoing hepatectomy, randomly selected from January 2011 to April 2016. The patient features are shown in Table 1 .
The FLR, defined as the percentage of functional hepatic remnant after hepatectomy, was estimated, as previously described. 17 Four patients underwent portal venous embolization, preceded by percutaneous biliary drainage of the liver remnant, as mentioned above. 4 Twenty-one patients were previously or concomitantly subjected to metastasis thermoablation of the liver remnant. Mortality was defined as death within the first 90 days after hepatectomy.
Control group
Fifteen patients, who underwent right hemicolectomy, were randomly chosen in the same period. This surgical procedure induces a significant and abrupt iatrogenic PVP increase without changing the remaining liver.
Measurement of portal venous pressure and surgical procedure
The hepatectomy techniques were performed according to previous description. 18 PVP was measured before and after hepatectomy, by introducing a 1.4 Fr catheter into the portal vein, attached to the transducer that measures venous pressure during intraoperative monitoring. Central venous pressure was maintained below 5 mmHg in both measures.
Portal venous pressure variation
The variation of PVP, defined as the difference between the values obtained after and before the procedure shows an average value = 2.33 ± 3.7 mmHg and median = 1 mmHg.
Study endpoints
The main endpoint of this study is to relate the variation of PVP, before and after hepatectomy, with: a) Variation of prothrombin time (PT) and international normalized ratio (INR), total bilirubin, albumin, aspartate transaminase, alanine aminotransferase, glutamic-oxalacetic transaminase (GOT), alkaline phosphatase (AP), lactic dehydrogenase (LDH), gama-glutamyltransferase (GGT) and creatinine, measured by serum assay in the last 15 preoperative days, at 24 hours and at the 30 th day of postoperative time. b) Clavien-Dindo morbidity score. Several factors related to the patient, to the disease and to the surgical procedure that may influence the relation under analysis were considered, as showed in Table 1 .
In the control group undergoing right hemicolectomy, hepatic function and cytolysis were evaluated through the variables already mentioned in the group of patients subjected to hepatectomy. Similarly, other outcome factors were considered.
Statistical analysis
The evaluation of normal distribution of quantitative variables was done according to the Shapiro-Wilk test. The comparison of continuous variables between two independent groups was done according to the independent samples t-Student test or the Mann-Whitney U test. The χ 2 test or the Fisher exact test was used for comparisons between categorical variables. For comparisons between ordinal or quantitative variables, the Rho-Spearman or the Pearson test were used.
The receiver operating characteristic (ROC) curve was applied to determine the optimal cut-off of the PVP variation, as a predictor of the outcome. Linear regression was applied to identify predictors of hepatic dysfunction and cytolysis. The significance check in the linear regression analysis was based on an F-test and the significance of single independent variables was assessed by a t-test. For the selection of variables in the multiple regression a stepwise approach was applied. To identify predictors of major complications or PHLF forward logistic regression (Wald test) was used. A significance of 0.05 was considered for all comparisons.
RESULTS

Univariate analysis
In this model, the PVP increase was associated with a coagulation impairment at 24 hours (INR24 hours: r = 0.447, p = 0.013) and on the fifth day after hepatectomy (INR5: r = 0.379, p = 0.039; PT5: r = -0.387, p = 0.038), compared to preoperative evaluation, as shown in Table 2 . On the 30 th postoperative day, the association between increased PVP after hepatectomy and coagulation impairment is still observed (INR30: r = 0.414, p = 0.032; PT30: r = -0.459, p = 0.01) ( Table 2 .) In addition, the PVP increase is related to the serum GOT increase (r = 0.525, p = 0.007) and serum AP increment (r = 0.701, p = 0.0001) in the 30 th day, enzymes whose concomitant serum assay is raised in the context of hepatic dysfunction ( Table 2) .
The PVP increase after hepatectomy is associated with the occurrence of major complications (p = 0.01). In addition, the PVP variation tends to increase with the appearance of PHLF defined by the IGSLS criteria (p = 0.041), as shown in Table 2 . In this sample, there was no association between the PVP increase after hepatectomy and PHLF, according to the '50-50 criteria', nor with postoperative mortality (Table 2) .
Considering the other factors that could interfere with the studied association, none revealed to influence the relation between the PVP variation and the outcome analysed. However, if we observe the influence of each factor on the outcome variables, we find that the decrease in FLR interferes with the coagulation impairment (INR24h: r = -0.492, p = 0.006; INR5: r = -0.474, p = 0.008). Besides that, chemotherapy prior to hepatectomy was associated with coagulation impairment in the fifth postoperative day (r = 0.362, p = 0.049).
Multivariate analysis
In the multiple linear regression model (Table 3) , when we analysed the cumulative effect of PVP variation during hepatectomy and FLR, we found that they influence the coagulation at 24 hours, accounting for 32.5% of the INR variance (r 2 = 0.325, p < 0.01). The PVP increase after hepatectomy causes an INR increment at 24 postoperative hours (ß = 0.385, p < 0.05), while, as expected, the FLR increase has an opposite effect on the INR (ß = -0.355, p < 0.05).
In addition, the results show that PVP variation and exposure to chemotherapy (CHEMO) prior to hepatectomy lead to a cumulative coagulation impairment, accounting for 35.8% of the INR variance on the 30th postoperative day (r 2 = 0.423, p < 0.01), through a positive effect of both (PVP: ß = 0.538, p < 0.01) (CHEMO: ß = 0.423, p < 0.05) ( Table 3) . The results also show that the PVP and FLR variation influence the degree of hepatic cytolysis after hepatectomy: it accounts for 61.1% of the AP serum assay variance on the 30 th postoperative day (r 2 = 0.611, p < 0.001). While the former causes an AP serum increment (ß = 0.674, Carrapita JG, et p < 0.001), the second has an opposite effect (ß = -0.305, p < 0.05). This evidence is corroborated by the similar effect of the PVP increase on serum GGT on the 30th postoperative day (ß = 0.606; p < 0.01), being responsible for 36.8% of the serum GGT variance (r 2 = 0.368; p < 0.01) ( Table 3) . 
PVP variation cut-off during hepatectomy
The ROC curve shows that a PVP increment after hepatectomy greater than 1.5 mmHg is the optimal cut-off for the occurrence of major complications, with a sensitivity of 70% and specificity of 65% (AUC = 0.69), as shown in Fig. 1 .
By reclassifying the PVP variation as a binary variable (PVP < 2 mmHg and PVP ≥ 2 mmHg), in a univariate analysis, we confirm that patients undergoing hepatectomy and exhibiting a PVP increment ≥ 2 mmHg express a greater deterioration of the coagulation at 24 postoperative hours (INR24 hours: p = 0.006), which remains at the following time points (INR5: p < 0.029) (INR30: p = 0.033), compared to patients with a PVP increase < 2 mmHg. This greater coagulation impairment in the first 30 days after hepatectomy is confirmed by the serum LDH increase at 24 postoperative hours (p = 0.026) and by the serum AP increment on the 30 th postoperative day (p = 0.001), in the group of patients exhibiting PVP ≥ 2 mmHg, as shown in Table 4 .
In the stepwise linear regression analysis, it is shown that PVP increment ≥ 2 mmHg is an independent factor for the worse coagulation impairment after hepatectomy, accounting for 20.3% of the INR increase on the fifth postoperative day (r 2 = 0.203; p < 0.05), as shown in Table 3 . Moreover, it is shown, in a forward logistic regression model, that a PVP increment ≥ 2 mmHg after hepatectomy is also an independent factor for the occurrence of major complications, being clear that the patients with this condition have an 8.1% increased risk (OR = 0.124, p = 0.032) of major complications compared to patients with PVP < 2 mmHg (Table 3) .
Control group
Patients in the control group, undergoing right hemicolectomy without hepatic resection, exhibit a coagulation impairment in the first 24 hours after surgery, expressed by the INR increase (p = 0.014) and by PT decrease (p = 0.008), compared to the preoperative assays. On the fifth and 30 th postoperative days, coagulation improved, compared to the preoperative control. Furthermore, there is a serum albumin decrease in the first 24 hours, compared to the preoperative period (p = 0.001), which does not persist in the following time points.
If we analyse the cytolysis and the excretory and synthesis hepatic functions, we do not detect significant variation in the first 30 postoperative days.
DISCUSSION
This model demonstrates that PVP increase is a predictive factor of coagulation impairment, at 24 hours after hepatectomy, when analysed concomitantly with the future liver remnant. In addition, this coagulation impairment is maintained on the 30 th postoperative day, if we consider the joint influence of exposure to chemotherapy prior to hepatectomy. This hepatic functional decrease is corroborated by an increase in serum GGT and AP on the 30 th postoperative day, which are indicators of liver injury that are widely used in clinical practice. This association between increased PVP and hepatic functional deterioration also occurs in the control group in the first 24 hours, in which an increase in PVP is induced without associated hepatic resection, indicating that the increase in PVP has deleterious effects on the liver, in accordance with previous studies. 1, 7, 8, 11, [13] [14] [15] [16] However, unlike patients undergoing hepatectomy, there is a coagulation recovery at the following evaluation time points and a concomitant absence of additional hepatic dysfunction, indicating that deterioration of hepatic function after hepatectomy is multifactorial.
As in previous studies, 1, 3, 20 this work supports the hypothesis that the cause of liver function deterioration is not only the functional percentage of the remaining liver, but also other factors such as the PVP increase after hepatectomy and the exposure to chemotherapy prior to hepatectomy. Even though portal venous flow plays a significant role in liver regeneration, these quick hemodynamic changes can lead to excessive portal venous flow to the residual liver, which generates portal hyperperfusion. Several factors are implicated in the pathogenesis of this phenomenon, namely the increased production of reactive oxygen species and cytokines induced by hemodynamic changes which, by itself, leads to hepatocyte necrosis and apoptosis. Besides this, it is also reported that portal hyperperfusion destroys the hepatic sinusoidal network, by excessive shear forces on its walls, leading to periportal bleeding and endothelial destruction. Another explanation is based on the abrupt and excessive regenerative stimulus induced by portal hyperperfusion, which, particularly in the early hours, leads to excessive hepatocyte proliferation not supported by an organized sinusoidal network to ensure adequate blood supply to the hepatocytes, thus compromising liver function. 11 Previous investigations 1, 21 based on the measurement of PVP after hepatectomy or LDLT, attribute a post-hepatectomy PVP cut-off of 20 or 21 mmHg, from which the risk of hepatic failure is higher. However, they do not consider the baseline PVP before hepatectomy. Currently, the underlying mechanisms to PVP variation after hepatectomy are poorly understood in humans. In addition, the PVP variability in the human model is unknown, such as all the factors that may influence it. Thus, the novelty of this study is the prediction of the occurrence of severe hepatic dysfunction after hepatectomy considering PVP variation before and after hepatectomy and not only a single measurement after hepatectomy. This problem becomes more important if, in the future, we could define which patients benefit from the intraoperative portal influx modulation procedure, which may be an effective strategy for preventing hepatic failure after hepatectomy. 1, 22 However, this model has some limitations. One of them is the small sample size. Another problem is the selection of variables to perform the regression analysis, when a high number of independent variables that are candidates for the selection is present. To deal with this, a stepwise selection was performed. Eveb though stepwise regression analysis is popular, some authors consider that these methods are poor, because they may not identify sets of variables that fit well, even when such sets exist 23 and a parameter estimates are likely to be too far away from zero. 24 Nonetheless, despite these limitations, this model shows that a PVP increment ≥ 2 mmHg after hepatectomy worsens hepatic coagulation function during the first five postoperative days and carries an increased risk of major complications. In our opinion, this not only demonstrates the need to evaluate PVP variation intraoperatively, but may also influence other studies, contributing to the future definition of indications for portal influx modulation.
CONCLUSION
PVP increase during hepatectomy influences the deterioration of liver function in the postoperative period. A PVP increase ≥ 2 mmHg after hepatectomy, compared to baseline, increases the risk of major complications.
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